Ara
Toplam kayıt 1, listelenen: 1-1
MONOCYTE COUNT TO HDL-CHOLESTEROL RATIO MAY BE A NOVEL CARDIOMETABOLIC MARKER IN PATIENTS WITH FUNCTIONAL ADRENAL TUMORS
(2019)
OBJECTIVE: The monocyte count to HDL-Cholesterol ratio (MHR) was increased in patients with cardiovascular disease and, showed as an indicator of cardiovascular risk factors. Functional adrenal tumor and even nonfunctional ...